Comparison between cytisine and Nicotine Replacement Therapy in smoking cessation among inpatient psychiatric patients.

What Was Tested

Researchers studied Therapeutic nicotine (patch, non-peptide) in this randomized controlled trial publication.

In this study, the effect of cytisine on the smoking status of patients hospitalized in the psychiatry department was investigated.

Who Took Part

The age groups tagged for this paper are adults and middle-aged adults, both men and women.

Forty-seven patients, hospitalized in the psychiatry ward, motivated to quit smoking, participated in this open-label randomized trial.

How the Study Was Run

The researchers set it up as a randomized and open-label study.

Random assignment meant chance, not the researchers, decided who got Therapeutic nicotine (patch, non-peptide) and who got the comparison, which limits bias.

Everyone knew when Therapeutic nicotine (patch, non-peptide) was being given (open label), which is simpler to run but leaves more room for expectations to affect what is reported.

The primary outcome was smoking cessation, measured by the mood and physical symptoms scale (MPSS), the AUDIT alcohol consumption questions (AUDIT-C), confirmatory factor analyses, and reliability of the modified cigarette evaluation questionnaire at the end of the 1st week and at 1st, 2nd and 6th months after quit day.

What Was Measured

PubMed files the paper under topics including Azocines, Quinolizines, Smoking Cessation, Alkaloids, Tobacco Use Cessation Devices, Mental Disorders and Inpatients.

Author keywords: Cytisine, nicotine replacement therapy and psychiatry.

What This Means in Plain Language

The paper is a randomized and open-label study of Therapeutic nicotine (patch, non-peptide).

The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2024 (Journal of addictive diseases), a journal based in England.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.